Details of the Drug

General Information of Drug (ID: DM7EBH9)

Drug Name
ALX-0081
Indication
Disease Entry ICD 11 Status REF
Thrombotic thrombocytopenic purpura 3B64.14 Phase 3 [1]
Thrombocytopenia 3B64 Phase 2 [2]
Cross-matching ID
TTD ID
D08POF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
von Willebrand factor (VWF) TT3SZBT VWF_HUMAN Binder [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Novel antiplatelet agents: ALX-0081, a Nanobody directed towards von Willebrand factor. J Cardiovasc Transl Res. 2013 Jun;6(3):355-63.
3 Clinical pipeline report, company report or official report of Ablynx